186 related articles for article (PubMed ID: 6766292)
1. Antibiotic susceptibility of beta-lactamase-producing strains of Branhamella (Neisseria) catarrhalis.
Doern GV; Siebers KG; Hallick LM; Morse SA
Antimicrob Agents Chemother; 1980 Jan; 17(1):24-9. PubMed ID: 6766292
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.
Liljequist BO; Gezelius L
Eur J Clin Microbiol; 1986 Dec; 5(6):615-21. PubMed ID: 3492374
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis.
Alvarez S; Jones M; Holtsclaw-Berk S; Guarderas J; Berk SL
Antimicrob Agents Chemother; 1985 Apr; 27(4):646-7. PubMed ID: 3873905
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of BRL 17421 against Haemophilus influenzae, Neisseria gonorrhoeae, and Branhamella catarrhalis.
Piot P; Van Dyck E
Antimicrob Agents Chemother; 1982 Jan; 21(1):166-7. PubMed ID: 6805422
[TBL] [Abstract][Full Text] [Related]
5. Clinical interpretation of beta-lactamase-producing strains of Branhamella catarrhalis in sputum Gram's stain and culture.
Robinson A; Johnson PC; Griffith SB
Am J Clin Pathol; 1987 Apr; 87(4):498-503. PubMed ID: 3548321
[TBL] [Abstract][Full Text] [Related]
6. Detection, distribution and inhibition of Branhamella catarrhalis beta-lactamases.
Philippon A; Riou JY; Guibourdenche M; Sotolongo F
Drugs; 1986; 31 Suppl 3():64-9. PubMed ID: 3015547
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of Branhamella catarrhalis to oral antibiotics.
Kallings I
Drugs; 1986; 31 Suppl 3():17-22. PubMed ID: 3488193
[TBL] [Abstract][Full Text] [Related]
8. The incidence and antibiotic susceptibility of Branhamella catarrhalis in respiratory infections.
Calder MA; Croughan MJ; McLeod DT; Ahmad F
Drugs; 1986; 31 Suppl 3():11-6. PubMed ID: 3488189
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial activity of nine oral antibiotics against Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis.
Renkonen OV
Scand J Infect Dis Suppl; 1983; 39():106-8. PubMed ID: 6606222
[TBL] [Abstract][Full Text] [Related]
10. Disk diffusion susceptibility of Branhamella catarrhalis and relationship of beta-lactam zone size to beta-lactamase production.
Luman I; Wilson RW; Wallace RJ; Nash DR
Antimicrob Agents Chemother; 1986 Nov; 30(5):774-6. PubMed ID: 3492178
[TBL] [Abstract][Full Text] [Related]
11. [Susceptibility of Branhamella catarrhalis to antibiotics].
Leszczyńska K; Jakoniuk P; Sacha PT; Zalewska M; Wieczorek P
Med Dosw Mikrobiol; 2004; 56(3):231-7. PubMed ID: 15773499
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility of Branhamella catarrhalis isolates from bronchopulmonary infections.
Ahmad F; McLeod DT; Croughan MJ; Calder MA
Antimicrob Agents Chemother; 1984 Sep; 26(3):424-5. PubMed ID: 6508272
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of 50 non-beta-lactamase-producing Neisseria gonorrhoeae strains to 12 antimicrobial agents.
Rodríguez J; Fuxench-Chiesa Z; Ramírez-Ronda CH; Kouri Y; Cuevas R; Nevárez M; Pérez M
Antimicrob Agents Chemother; 1983 Feb; 23(2):242-4. PubMed ID: 6404217
[TBL] [Abstract][Full Text] [Related]
14. [Serotype distribution and drug resistance of
Tian HL; Shi W; Zhou HF; Yuan L; Yao KH; Rexiati D; Xu AM
Zhonghua Er Ke Za Zhi; 2018 Apr; 56(4):279-283. PubMed ID: 29614568
[No Abstract] [Full Text] [Related]
15. In vitro susceptibilities of isolates from patients with Branhamella catarrhalis pneumonia compared with those of colonizing strains.
Sweeney KG; Verghese A; Needham CA
Antimicrob Agents Chemother; 1985 Apr; 27(4):499-502. PubMed ID: 3873899
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of Yersinia kristensenii strains to beta-lactam antibiotics.
Bejar V; Calvo C; Ramos Cormenzana A
Ann Inst Pasteur Microbiol (1985); 1986; 137A(2):169-77. PubMed ID: 3501272
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of Haemophilus influenzae to amoxicillin/clavulanic acid, erythromycin, cefaclor, and trimethoprim/sulfamethoxazole.
Doern GV; Chapin KC
Diagn Microbiol Infect Dis; 1986 Jan; 4(1):37-41. PubMed ID: 3484692
[TBL] [Abstract][Full Text] [Related]
18. Clinical and bacteriological evaluation of Branhamella catarrhalis in respiratory infections.
Saito A; Yamaguchi K; Shigeno Y; Kohno S; Shigeno H; Kusano N; Dotsu Y; Hara K
Drugs; 1986; 31 Suppl 3():87-92. PubMed ID: 3488201
[TBL] [Abstract][Full Text] [Related]
19. Activity of common antibiotics against Branhamella catarrhalis, Haemophilus influenzae, pneumococci, group A streptococci and Staphylococcus aureus in 1983.
Forsgren A; Walder M
Acta Otolaryngol Suppl; 1984; 407():43-9. PubMed ID: 6437134
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility and beta-lactamase characterization of Branhamella catarrhalis isolates from 1983/1984 and 1988.
Christensen JJ; Keiding J; Bruun B
APMIS; 1990 Nov; 98(11):1039-44. PubMed ID: 2123390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
